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Haemophilus ducreyi can bind hemoglobin and use it as a source of heme, for which it has an obligate
requirement. We previously identified and purified HgbA, a hemoglobin-binding outer membrane protein from
H. ducreyi. In this report, we describe the molecular cloning, expression, DNA sequence, and mutagenesis of the
structural gene for HgbA, hgbA. H. ducreyi and recombinant Escherichia coli expressing hgbA bound [125I]he-
moglobin, establishing HgbA as a receptor. Insertions or deletions in the cloned hgbA gene abolished expres-
sion of HgbA and hemoglobin binding in E. coli. Mutagenesis of H. ducreyi by allelic exchange of insertions into
hgbA abolished its ability to bind [125I]hemoglobin or utilize hemoglobin as a source of heme. The deduced
protein sequence was similar to those of the TonB-dependent family of outer membrane receptors. The most
similar member was HutA (heme receptor) from Vibrio cholerae. Tbp1 and Lbp1 (transferrin and lactoferrin
receptors, respectively, from pathogenic Neisseria spp.) also showed very significant homology. Thus, by
characterizing the hgbA locus, this work elucidates a potentially important role of HgbA in obtaining heme
and/or iron from the host.
Haemophilus ducreyi is the etiologic agent of the sexually
transmitted disease chancroid (1, 17). Chancroid is character-
ized by ulcerative lesions present on or near the genitals and is
sometimes associated with buboes of the inguinal lymph nodes
(1, 17). There is an increased incidence of human immunode-
ficiency virus type 1 (HIV-1) seroconversion for male clients of
HIV-1-infected female sex workers who have genital ulcers,
suggesting that genital lesions provide a more efficient exit for
the HIV-1 virus (23, 31). It has been proposed that the rapid
heterosexual spread of HIV-1 in eastern and southern Africa
has in large part been due to concomitant genital ulcer disease
(24). Thus, eradication of chancroid and other genital ulcer
diseases could enhance HIV-1 control programs. At the
present time, no vaccine is available and no vaccine candidates
are on the horizon.
H. ducreyi is a fastidious, slowly growing, gram-negative rod
that is unable to synthesize heme (2). In vitro, H. ducreyi must
be supplied with heme or heme-containing compounds such as
hemoglobin (Hgb) for aerobic growth (2, 13). The in vivo
sources of heme are not known; however, H. ducreyi is hemo-
lytic (21), which may provide a source of Hgb and therefore a
source of heme. An additional uncharacterized step(s) for
heme release and internalization remains to be elucidated.
Iron is needed by nearly all bacteria (32). Iron starvation is
a major obstacle which infecting bacteria must overcome (19).
Some bacteria obtain iron via iron-scavenging siderophore sys-
tems (19) or utilize host iron found in transferrin or lactoferrin
(4, 20); H. ducreyi does neither (13). It is possible that iron
contained in heme or Hgb could serve as an iron source for H.
ducreyi in vivo.
Elkins previously identified and isolated a conserved Hgb-
binding outer membrane protein from H. ducreyi termed
HgbA (6). In this communication, we report the cloning, mu-
tagenesis, expression, DNA sequence, and characterization of
the gene encoding HgbA, which we have termed hgbA.
MATERIALS AND METHODS
Bacteria and growth conditions. The H. ducreyi type strain, 35000, was ob-
tained from Stanley Spinola, Indiana University, Bloomington, Ind. H. ducreyi
strains were routinely passaged every 48 h on chocolate agar. For growth of H.
ducreyi strains under heme-limiting conditions on solid medium (see Fig. 3),
bacteria were heavily inoculated onto gonococcal medium base (GC Base; Difco,
Detroit, Mich.) supplemented with 1% Isovitelex (Baltimore Biological Labora-
tory, Cockeysville, Md.) (GCB-I) and either 5 mg of heme per ml (heme deplete)
or 50 mg of heme per ml (heme replete) (6).
Cloning of the gene encoding HgbA. Standard methods were followed for
molecular biological techniques (16). Oligonucleotides were synthesized at the
Lineberger Cancer Center DNA Synthesis Facility at the University of North
Carolina at Chapel Hill and were used without further purification. DNA hy-
bridizations were performed with the Genius system according to the directions
of the manufacturer (Boehringer Mannheim Corp., Indianapolis, Ind.). Oligo-
nucleotides were labeled with a terminal transferase kit, and plasmid DNA was
labeled with a random prime kit (Genius).
The hgbA gene was cloned by ligating size-selected EcoRI chromosomal DNA
fragments from H. ducreyi 35000 into EcoRI-predigested and prephosphorylated
lambda ZAPII arms according to the manufacturer’s directions (Stratagene, San
Diego, Calif.). After infection and plating of Escherichia coli XL1 Blue, the
resulting plaques were screened with the degenerate oligonucleotide HgbA1.01
(Fig. 1), which was designed on the basis of the N-terminal amino acid sequence
of HgbA (6). Hybridizations and stringency washes with 23 SSC (13 SSC is 0.15
M NaCl plus 0.015 M sodium citrate) were done at 508C. Positive plaques were
subjected to two rounds of purification and excised as Bluescript plasmids ac-
cording to the directions of the manufacturer (Stratagene). A representative
plasmid, pUNCH 579, was chosen for further study. Subclones of pUNCH 579
were made (Fig. 2) and were constructed with the vector Bluescript (Stratagene).
DNA sequencing.Double-stranded sequencing was performed with Sequenase
(U.S. Biochemicals) according to the directions of the manufacturer. Both
strands of the 59 region of hgbA were sequenced from pUNCH 555 with synthetic
oligonucleotides in the authors’ laboratory. Subclones pUNCH 553 and pUNCH
557 were subjected to nested deletions with exonuclease III and S1 nuclease, and
both strands were sequenced by Lark Sequencing Technologies (Houston, Tex.)
(16). To orient subclones, the HindIII junctions were sequenced (Lark) with
pUNCH 579 being used as the template.
Construction of hgbA isogenic mutants. The gene encoding chloramphenicol
acetyltransferase (CAT cassette) was excised on a 1.6-kb HindIII fragment from
plasmid pNC 40 (28) and used to mutagenize pUNCH 579. This CAT cassette
was originally derived from mini-Tn3 (25). Plasmid pUNCH 579 was partially
digested with HindIII, the linear form was isolated, and it was ligated with the
1.6-kb CAT cassette. Chloramphenicol-resistant transformants were subjected to
restriction analysis to identify insertions into each of the three HindIII sites
contained within the insert of pUNCH 579. Insertions were isolated and termed
pUNCH 580, 581, and 582 for the A, B, and C HindIII insertions, respectively,
as designated in Fig. 2. H. ducreyi was electroporated with pUNCH 580, pUNCH
581, and pUNCH 582, and recombinants were selected on plates containing 1.0* Corresponding author.
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mg of chloramphenicol per ml (8). Screening of H. ducreyi transformants for
expression of HgbA was performed by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and Western blotting (immunoblotting) as
described below.
Growth of mutant FX504 on Hgb and human blood agar. In order to test the
ability of human Hgb to support the growth of H. ducreyi 35000 and the various
H. ducreyi hgbA mutants, GCB-I agar containing 0, 50, 100, 500, and 1,000 mg of
human Hgb (Sigma, St. Louis, Mo.) per ml was prepared as previously described
(6). A single colony from a chocolate agar plate was streaked for isolation onto
Hgb plates, incubated for 48 to 72 h, and examined for growth. The positive
control for growth was a GCB-I plate containing 50 mg of heme per ml, and the
negative control was a GCB-I plate lacking heme or Hgb; both were inoculated
with wild-type H. ducreyi 35000. Determinations of whether human erythrocytes
could support extended growth were made by streaking isolated colonies from
chocolate agar medium onto GCB-I containing 5% washed human erythrocytes.
Immunoassays and Hgb dot blots. SDS-PAGE (12), Western blots (29), and
dot blots (6) were carried out as previously described, with the following excep-
tions.
For Western blotting of E. coli clones, bacteria were grown overnight on
Luria-Bertani agar (to avoid problems of instability) containing 100 mg of am-
picillin per ml and suspended at an optical density at 600 nm of 0.4. A 1-ml
portion of this suspension was pelleted, and the pellet was resuspended in 150 ml
of Laemmli sample buffer. This was boiled, and 50 ml of the suspension per lane
was loaded on an SDS–7.5% PAGE gel (approximately 25 mg of protein). HgbA
antibodies used in this study were those raised against a synthetic peptide based
on the N-terminal amino acid sequence of HgbA (6). Since these antibodies
recognize the N terminus of HgbA, they would be expected to recognize trun-
cated forms of the protein.
E. coli clones used in the dot blots were grown as described above and
suspended at an optical density at 600 nm of 0.4. Portions (100 ml) of the
suspension were immobilized onto nitrocellulose. These dot blots were probed
with 125I-labeled human Hgb as previously described for H. ducreyi (6).
The original screening of E. coli clones expressing hgbA was done by probing
dot blots with biotinylated human Hgb. Human Hgb (Sigma) was biotinylated
with a 40:1 molar excess of N-hydroxysuccinimidobiotin (Pierce, Rockville, Ill.)
to Hgb according to the directions of the manufacturer. Excess biotin was
removed by dialysis. The binding of biotin-labeled Hgb was detected in dot blots
by probing them with streptavidin conjugated to horseradish peroxidase (Pierce)
and developing them with the substrate Enzygraph (Kodak, Rochester, N.Y.).
Endogenous peroxidase in H. ducreyi prevented the use of peroxidase-containing
reagents for H. ducreyi dot blots (data not shown).
Nucleotide sequence accession number. The nucleotide sequence presented in
this communication has been deposited with GenBank and has been given the
accession number U17281.
RESULTS
Cloning of the DNA fragment encoding HgbA. On the basis
of the N-terminal sequence of HgbA (6), we deduced a degen-
erate oligonucleotide mixture (termed HgbA1.01) (Fig. 1) and
used it to probe separate restriction digests of the chromosome
of H. ducreyi 35000. In each chromosomal digest, HgbA1.01
hybridized to a single band (data not shown). Digestion of
chromosomal DNA from 35000 with EcoRI revealed a band of
approximately 8.5 kb that hybridized with HgbA1.01. This size
is an appropriate size insert for cloning in lambda vectors. The
lambda ZAPII system was used to clone the gene encoding
HgbA. We probed plaques containing EcoRI-digested, size-
selected H. ducreyi inserts with digoxigenin-labeled HgbA1.01
oligonucleotide and obtained five recombinants which hybrid-
ized strongly. These five plaques were excised into Bluescript
form. The five recombinants were screened for the binding of
biotinylated Hgb to whole cells in a dot blot, and all five bound
Hgb; the Bluescript vector control did not bind Hgb (data not
shown). Each recombinant contained an 8.5-kb fragment
which hybridized in a Southern blot to an identical-sized
EcoRI fragment in the chromosome of H. ducreyi 35000 (data
not shown). One clone was designated pUNCH 579 and was
used throughout the following experiments. Subclones of
pUNCH 579 were made as shown in Fig. 2. Insertions into
pUNCH 579 were made by ligation of the antibiotic CAT
cassette into each of the three HindIII sites within the insert of
pUNCH 579 in E. coli (Fig. 2; also see Materials and Meth-
ods).
Expression of HgbA in E. coli. Several lines of evidence were
sought to determine whether pUNCH 579 contained the struc-
tural hgbA gene. Western blots were probed with affinity-puri-
fied immunoglobulin G antibodies raised against the HgbA N-
terminal peptide. The recombinant E. coli containing pUNCH
579 expressed a protein which comigrated with native HgbA
(Fig. 3A; compare lanes 1 and 3); as expected, the vector
control was negative (Fig. 3A, lane 14). Whole-cell dot blots
were probed with 125I-labeled human Hgb. Recombinant E.
coli containing pUNCH 579 expressed an Hgb binding pheno-
type, but the vector control was negative (Fig. 3B; compare
lanes 3 and 14). These data strongly suggested that pUNCH
579 contained the entire hgbA gene and that HgbA was a
receptor for Hgb. Binding of [125I]Hgb was inhibited by an
excess of unlabeled Hgb (Fig. 3C, lane 3), demonstrating that
the binding was specific (as discussed below).
Localization of the hgbA gene in pUNCH 579. Several strat-
egies were used to localize the hgbA structural gene, including
hybridization, limited DNA sequencing and Western blotting
of subclones, and insertions into pUNCH 579. Hybridization
with Hgb1.01 (degenerate oligonucleotide deduced from the
N-terminal peptide sequence) localized the N terminus of
hgbA to a 700-bp EagI-to-HindIII fragment roughly in the
center of the insert contained in pUNCH 579 (Fig. 2). Since
just under 3 kb of DNA should be sufficient to encode the
100-kDa HgbA protein, the central location for the N terminus
of the gene allowed for either orientation of hgbA. Limited
sequencing established the orientation of hgbA shown in Fig. 2.
Western blotting of CAT insertions and subclones was used to
confirm the localization and orientation of hgbA. Only sub-
FIG. 1. Synthesis of an oligonucleotide probe. The top single-letter-code
sequence (Seq) of amino acids is the N-terminal, 14-amino-acid (aa) sequence
from purified HgbA. The middle degenerate sequences are all the possible DNA
sequences which could encode the 14 N-terminal amino acids. The lower se-
quence is the sequence of the degenerate oligonucleotides used in probe
Hgb1.01 (64 different oligonucleotides).
FIG. 2. Restriction map of hgbA and flanking DNA. An approximately 8-kb
EcoRI fragment was cloned into lambda ZAPII and excised as a Bluescript
plasmid to form pUNCH 579. Plasmids pUNCH 550 thru 557 are subclones.
Plasmids pUNCH 580, 581, and 582 are plasmid pUNCH 579 with a 1.6-kb CAT
cartridge inserted into HindIII sites A, B, and C, respectively. Also shown is a
summary of HgbA expression (Fig. 3).
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clone pUNCH555 and insertion pUNCH 582 were capable of
expressing full-length HgbA (Fig. 2 and 3). On the basis of
these data, subclones pUNCH551, pUNCH553, and pUNCH
557 were chosen to complete the sequence of hgbA.
DNA sequence analysis and predicted protein. The nucle-
otide sequence of hgbA is presented in Fig. 4. One potential
235 and 210 promoter region is indicated; however, two oth-
ers exist in this upstream region. A putative Fur box is shown,
and it contains within it the 235 sequence. An inverted repeat
consistent with a transcription termination signal is just down-
stream of the open reading frame. A ribosome binding site,
AGGAA, is just upstream of the start codon. The open reading
frame starts at nucleotide 244 and ends at nucleotide 3159. The
open reading frame of 2,919 nucleotides encodes a protein
with a calculated molecular weight of 110,936. The predicted
protein has phenylalanine at the C terminus, as do most other
outer membrane proteins (27). The 14 amino acids obtained by
Edman degradation of the purified HgbA protein (6) (Fig. 1)
were identical to deduced amino acids 23 to 36, unambiguously
confirming that we had cloned the gene encoding HgbA. The
first 22 deduced amino acids consisted of a typical signal pep-
tidase I leader peptide and contained the appropriate charged
amino acids followed by a hydrophobic region (30). A consen-
sus signal peptidase I cleavage site of AXA was not present
FIG. 3. Western blots and dot blots of H. ducreyi and recombinant E. coli
expressing hgbA. H. ducreyi and recombinant E. coliDH5aMCR containing all of
hgbA, portions of hgbA, or insertions into hgbA were subjected to Western
blotting (A) or dot blotting (B and C). Western blots in panel A were probed
with anti-HgbA. The dot blots in panel B were probed with 125I-labeled human
Hgb, and the dot blots in panel C were probed with a mixture of 125I-labeled
human Hgb and a 100-fold excess of unlabeled Hgb. Lane 1 is H. ducreyi 35000;
lane 2 is H. ducreyi hgbA mutant FX504. Lanes 3 to 14 are recombinant E. coli
containing the following plasmids: lane 3, pUNCH 579; lane 4, pUNCH 550; lane
5, pUNCH 551; lane 6, pUNCH 552; lane 7, pUNCH 553; lane 8, pUNCH 554;
lane 9, pUNCH 555; lane 10, pUNCH 557; lane 11, pUNCH 580; lane 12,
pUNCH 581; lane 13, pUNCH 582; and lane 14, Bluescript vector control.
Similar results were seen in at least one other experiment for all strains.
FIG. 4. Nucleotide sequence of hgbA. The deduced amino acid sequence is shown in single-letter code below the nucleotide sequence. A putative 210 and 235
promoter sequence, a putative Fur box, and the ribosome binding site (RBS) are indicated and labeled. The signal peptide is indicated by the underlined amino acids.
An asterisk indicates the termination codon. Arrows indicate a potential transcriptional terminator stem-loop structure.
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(30), but an alternative sequence VYA was present. This signal
peptidase I cleavage site is similar to those proposed for other
related receptor proteins (Fig. 5) (3) and is identical to that of
meningococcal Tbp1 from strain B16B6 (14). Cleavage at this
site would yield a mature deduced protein of 108,572 Da,
which is in agreement with the observed mobility on SDS-
PAGE gels. The calculated pI of HgbA is 9.9 and is consistent
with the basic nature of the related receptor proteins (see below).
FIG. 5. Homology between HgbA and TonB-dependent outer membrane proteins. (A) A comparison of the amino acid sequences of HgbA and the three proteins
most similar to it found in GenBank is shown. HgbA, Hgb-binding protein from H. ducreyi 35000 (this study); Tbp1, transferrin-binding protein from gonococcal strain
FA19 (3); Lbp1 (IroA), lactoferrin-binding protein from meningococcal strain BNCV (22); HutA, heme receptor from V. cholerae CA401 (9). The alignment was
generated with the default parameters in the Pileup program (5) and by manual alignment of the signal peptide and TonB boxes. The 11 residues of the putative TonB
boxes are underlined. The asterisks over the T and V residues indicate the two most conserved positions within the TonB boxes (3). The reversed-face letters indicate
highly conserved residues; the shaded letters indicate moderately conserved substitutions. (B). Homology of the TonB boxes of E. coli FepA (15) and H. ducreyi HgbA.
Vertical lines, identical residues; colons, conserved substitutions; dots, semiconserved substitutions.
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Homology to other TonB-dependent proteins. The results of
a BLASTX search (2a) of GenBank revealed that the HgbA
protein was highly related to a group of TonB-dependent re-
ceptor proteins found in other mucosal pathogens (Table 1)
(4). The most similar protein was HutA (9), a 74-kDa heme
receptor from Vibrio cholerae, followed closely by the 100-kDa
transferrin receptors (3, 14) and lactoferrin receptor Lbp1
(IroA) (22) from Neisseria meningitidis and Neisseria gonor-
rhoeae. Somewhat less but still significant homology was ob-
served with E. coli FepA (15) and Yersinia enterocoliticaHemR
(26). A comparison of HgbA with selected members of this
family is shown in Fig. 5A; for reasons of brevity, only three
highly related proteins are compared.
FepA and certain other related Ton B-dependent receptors
from E. coli have been shown experimentally to be dependent
upon TonB for function (7, 15). Tbp1, IroA, and HutA have
been inferred to be TonB dependent on the basis of homology
to FepA and others. Several interspersed regions are con-
served throughout the TonB-dependent outer membrane pro-
tein receptors (3, 18). One region in particular, termed the
TonB box, located near the N terminus is highly conserved in
E. coli and is important in TonB function (7). The putative
TonB boxes of HgbA, Tbp1 (3), IroA (22), and HutA (9) were
aligned and underlined. Significant sequence diversity existed
among the TonB boxes of these four proteins. However, when
the TonB box of HgbA was compared with the FepA TonB box
(Fig. 5B), the comparison revealed that 10 of 11 residues were
similar and that 2 invariant residues were present in HgbA (3).
Other regions of homology within the TonB-dependent family
of proteins contain certain (invariant) residues (3, 18). HgbA
contains 12 of 13 invariant residues. Therefore, on the basis of
homology to FepA, we suggest that HgbA may be a TonB-
dependent receptor.
Construction of an isogenic hgbA mutant. The strategy of
allelic replacement of hgbA was used to make an isogenic
mutant. H. ducreyi 35000 was electroporated with linearized
DNAs from each of the three mutagenized plasmids shown in
Fig. 2. Transformants were obtained with pUNCH 580 and
pUNCH 581 but were not obtained with pUNCH 582. Chlor-
amphenicol-resistant H. ducreyi transformants were screened
for the inability to grow on Hgb agar plates and by SDS-PAGE
for lack of HgbA (data not shown). One H. ducreyi hgbA
isogenic mutant obtained by electroporation with pUNCH 580
was termed FX504 and was extensively characterized. Another
hgbA mutant obtained by electroporation with pUNCH 581
and termed FX507 had a phenotype identical with that of
FX504 (data not shown).
Southern blot analysis of mutant FX504. To confirm that
FX504 arose as a simple allelic exchange event between
pUNCH 580 and the chromosome of H. ducreyi 35000, we
performed Southern blots of EcoRI digests of strain 35000 and
FX504 (Fig. 6). The blots were probed with pUNCH 579,
which contains the hgbA gene (Fig. 6A), or pNC 40, which
contains the CAT cassette (Fig. 6B). The insert of pUNCH 579
hybridized to itself, a comigrating 8.5-kb EcoRI fragment in H.
ducreyi 35000, and the two halves of the mutagenized 8.5-kb
EcoRI fragment in both pUNCH 580 and FX504 (the CAT
cassette introduces an additional 1.6 kb of DNA containing an
additional EcoRI site into the middle of the EcoRI fragment
from pUNCH 580). The CAT cassette hybridized only to the
two halves of the mutagenized 8.5-kb EcoRI fragment in both
pUNCH 580 and FX504. The hybridization with a 3-kb frag-
ment in both plasmid digests shown in both panels of Fig. 6 was
due to the presence of plasmid sequences in the DNA used to
make the probes. These data indicated that FX504 was the
result of a double crossover gene replacement event between
pUNCH 580 and H. ducreyi 35000.
Characterization of isogenic mutant FX504. The hgbA mu-
tant FX504 was further characterized by performing Western
blots and dot blots. FX504 expressed no detectable HgbA by
Western blot analysis and no Hgb binding activity in dot blots
(Fig. 3A and B, respectively; compare lanes 1 and 2).
The ability of the hgbA mutant FX504 to grow on human
Hgb was tested by preparing GCB-I plates containing various
concentrations of Hgb. Single colonies were streaked for iso-
lation onto plates to obtain data (Fig. 7). Mutant FX504 could
not grow on plates containing 100 mg of human Hgb per ml,
whereas the wild-type 35000 grew well (Fig. 7). Both strains
grew on GCB-I plates with 50 mg of heme per ml (positive
control), and neither strain grew on GCB-I plates without
heme or Hgb (negative control) (data not shown). The mini-
mum amount of Hgb which could support the growth of parent
H. ducreyi 35000 varied from 50 to 100 mg/ml. Depending on
the lot of Hgb agar, FX504 grew in some experiments on 500
or 1,000 mg of Hgb per ml, but in all experiments, the wild-type
35000 always exhibited an at least 10-fold lower requirement
for human Hgb than FX504 (data not shown).
The ability of the hgbA mutant FX504 to grow on human
blood agar plates was also tested. Initial subculture of a single
FIG. 6. Southern blotting of H. ducreyi 35000 and hgbA mutant FX504. Plas-
mids pUNCH 579 and pUNCH 580 and chromosomal DNA from H. ducreyi
35000 and hgbA mutant FX504 were each digested with EcoRI and subjected to
Southern blotting. The membrane was first probed with random primed pUNCH
579 (A), stripped, and then reprobed with random primed pNC 40 (containing
the CAT cassette) (B). Lane 1, plasmid pUNCH 579; lane 2, plasmid pUNCH
580; lane 3, chromosomal DNA from H. ducreyi 35000; lane 4, chromosomal
DNA from hgbA mutant FX504.
TABLE 1. Similarity and identity of proteins related to HgbA
Protein Bacterial species % Similar % Identical Reference
HutA V. cholerae 55 31 9
Tbp1 N. gonorrhoeae and N. meningitidis 47–50 25–27 3, 14
Lbp1 (IroA) N. gonorrhoeae and N. meningitidis 48–50 25–26 4, 22
HemR Yersinia pestis 48 26 26
FepA E. coli 47 24 15
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colony by the streaking of FX504 onto 5% human blood agar
resulted in tiny colonies which appeared to be strongly beta-
hemolytic, considering the sparse growth (data not shown).
The parent H. ducreyi 35000 grew well but was minimally
beta-hemolytic. A subculture from growth on the first blood
plate to a second blood agar plate resulted in no growth for
FX504 and continued normal growth of H. ducreyi 35000 (Fig.
7B).
It has previously been shown that animal Hgbs can support
the growth of H. ducreyi as well as compete with human Hgb
for binding to H. ducreyi (6). The ability of animal Hgbs to
support the growth of FX504 was further tested. Baboon, pig,
sheep, horse, bovine, dog, rabbit, or mouse Hgb could not
support the growth of FX504, while all supported the growth of
H. ducreyi 35000 (data not shown).
DISCUSSION
Purification of HgbA (6) led to the development of a degen-
erate oligonucleotide and an N-terminal peptide serum, which
were used to clone and characterize hgbA. Even though the
deduced oligonucleotide HgbA.01 was 64-fold degenerate, it
hybridized strongly in Southern blots and was used successfully
in sequencing reactions to obtain preliminary DNA sequences.
The N-terminal anti-peptide serum helped to prove that we
had cloned hgbA, established the orientation and localization
of hgbA, and confirmed that the hgbA mutants did not produce
HgbA.
Cloning of hgbA was readily performed by standard meth-
ods. We did notice, however, that clones expressing the full-
length HgbA product grew more slowly and were more likely
to undergo lysis and that pUNCH 579 was somewhat unstable.
In addition to E. coli DH5aMCR, three other strains of E.
coli harboring pUNCH 579 bound Hgb (data not shown), thus
establishing HgbA as an Hgb receptor. The cellular location of
HgbA in E. coli is uncertain. We were unable to affinity purify
the protein by the same technique that we used for H. ducreyi
(6). The binding seen in the whole-cell dot blots of E. coli
expressing hgbA could have been due to the outer membrane
localization of HgbA. Since E. coli clones expressing hgbA
lysed more readily, lysis of the cells during the assay could have
resulted in the exposure of cytoplasmic or periplasmic HgbA
and subsequent binding activity. Regardless, the binding dem-
onstrated by E. coli expressing hgbA was specific, since it could
be inhibited by unlabeled Hgb (Fig. 3C).
The DNA sequence of hgbA was typical of those of other
members of this family of outer membrane receptors. DNA
from Haemophilus spp. is AT rich, and the hgbA sequence
shown contains 65% AT nucleotides. Since 210, 235, and Fur
box sequences are also high in AT nucleotides, assigning func-
tional significance to AT-rich DNA is problematic. Thus, these
designations should be considered tentative until proven ex-
perimentally. The level of HgbA in E. coli DH5aMCR was not
regulated by the chelator 2,2-dipyridyl, possibly because of a
copy effect or lack of heterologous repression.
The similarity of HgbA and other established TonB-depen-
dent receptors suggests that HgbA is a receptor. Many recep-
tors of this class are involved in iron acquisition and have been
shown to be transport proteins for their ligands (such as FepA,
HemR, and HutA). Other receptors such as Tbp1, alone or in
conjunction with other proteins, remove iron from the host
iron-containing protein and transport iron across the outer
membrane. It is possible that HgbA could remove the heme
from Hgb and transport heme across the outer membrane. We
tested whether the hgbA gene product could complement the
growth of hemA E. coli RK1065 (11). However, the results
were uninterpretable, since a control for leakage of the
periplasmic enzyme RNase I (33) by the recombinant hemA
strain expressing HgbA was strongly positive (data not shown).
Thus, if RNase I could leak out, heme could leak in, invalidat-
ing any complementation experiments.
Recently, the gene encoding the TonB protein from Hae-
mophilus influenzae was cloned and sequenced (10). A func-
tional TonB protein is required in H. influenzae for heme
utilization (10). These data, taken together with the TonB box
homology present in HgbA, make it likely that a TonB protein
exists not only in H. influenzae but in H. ducreyi also. If an H.
ducreyi TonB homolog gene is cloned, the TonB dependence
of HgbA can be ascertained in its homologous system, where
HgbA does not cause lysis or leakage.
Other members of this receptor family are known to be
regulated by the negative transcriptional repressor Fur (20).
Under high-iron growth conditions, Fur complexes with iron
and binds to the Fur box of iron-regulated genes, blocking
transcription. Under low-iron growth conditions, Fur is not
complexed with iron and disassociates from the promoters and
the genes are derepressed. In contrast, it is reported that low-
heme conditions, not low-iron conditions, enhanced the ex-
pression of HgbA in H. ducreyi (6). If heme is the major source
of intracellular iron in H. ducreyi, Fur could be responsible for
the repression of hgbA expression under high-heme conditions.
A comparison of the HgbA sequence with the individual
peptide sequences of Tbp1, Lbp1 (IroA), HutA, HemR, and
FepA yielded significant similarities (Table 1). Even more re-
vealing was the comparison of the four proteins in Fig. 5A. A
region of striking dissimilarity was present in the central re-
gions of these four proteins (residues 220 to 670 for HgbA; Fig.
5A). Tbp1, Lbp1 (IroA), and HgbA (which bind protein li-
gands) contain certain domains absent from the heme receptor
HutA (which binds heme). Interestingly, Tbp1, Lbp1, and
HgbA contain divergent sequences in this domain. On the
basis of these observations, it is tempting to speculate that this
region of Tbp1, Lbp1, and HgbA contains the ligand binding
domain and that the diversity found in this region specifies the
ligand bound.
Mutagenesis of hgbA in H. ducreyi was performed by the
technique of electroporation (8). H. ducreyi mutant FX504 did
not express hgbA by Western blotting, bind human Hgb, or
grow on human Hgb or human blood plates. The initial sparse
growth of FX504 on human blood plates might have been due
to residual heme stores or possibly some heme leakage from
the erythrocytes, since these colonies were beta-hemolytic. The
strong beta-hemolysis observed with FX504 on this initial sub-
culture may indicate that the hemolysin of H. ducreyi is heme
or iron regulated. The inability to obtain H. ducreyi transfor-
FIG. 7. Ability of H. ducreyi 35000 and hgbA mutant FX504 to use human
Hgb as a source of heme or to grow on human blood agar plates.H. ducreyi 35000
(A) and hgbA mutant FX504 (B) were streaked onto a GCB-I agar plate (plate
1) containing 100 mg of human hemoglobin per ml and were streaked onto a
GCB-I agar plate (plate 2) containing 1% washed human erythrocytes and
incubated at 358C for 48 to 72 h. See the text for details. Similar results were seen
in at least two other experiments.
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mants with pUNCH 582 could have been due to the lethality of
this mutation, insufficient flanking DNA for recombination, or
other technical reasons.
It has been shown that various animal Hgbs can serve as a
source of heme for H. ducreyi in vitro. All tested animal Hgbs
supported the growth of wild-type strain 35000, but none sup-
ported that of HgbA isogenic mutant FX504. Thus, the role of
the Hgb receptor in the establishment and pathogenesis of
infection can be directly tested in animal models.
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